Xylo Technologies Ltd. - Asset Resilience Ratio
Xylo Technologies Ltd. (XYLO) has an Asset Resilience Ratio of 15.76% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Xylo Technologies Ltd.'s Asset Resilience Ratio has changed over time. Check Xylo Technologies Ltd. (XYLO) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Xylo Technologies Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Xylo Technologies Ltd. (XYLO) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.92 Million | 15.76% |
| Total Liquid Assets | $5.92 Million | 15.76% |
Asset Resilience Insights
- Good Liquidity Position: Xylo Technologies Ltd. maintains a healthy 15.76% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Xylo Technologies Ltd. Industry Peers by Asset Resilience Ratio
Compare Xylo Technologies Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Xylo Technologies Ltd. (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Xylo Technologies Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 15.76% | $5.92 Million | $37.55 Million | +10.79pp |
| 2023-12-31 | 4.98% | $3.18 Million | $63.90 Million | -0.13pp |
| 2022-12-31 | 5.10% | $4.99 Million | $97.65 Million | -0.45pp |
| 2021-12-31 | 5.55% | $3.31 Million | $59.73 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $32.34 Million | -- |
| 2017-12-31 | 48.52% | $3.50 Million | $7.21 Million | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more